G Kéri

A tumor-selective somatostatin analog (TT-232) with strong in vitro and in vivo antitumor activity.

G Kéri, J. Érchegyi, Anikó Horváth et al. · Proceedings of the National Academy of Sciences · 1996 · 97 citations

Tumor Biology, Oncology, Tumor-selective Somatostatin Analog +14

Inhibition of c-Met with the Specific Small Molecule Tyrosine Kinase Inhibitor SU11274 Decreases Growth and Metastasis Formation of Experimental Human Melanoma

István Kenessey, M Keszthelyi, Zachary Kramer et al. · Current Cancer Drug Targets · 2010 · 34 citations

Tyrosine Kinase, Immunology, Melanoma Progression +17

Effects of septic shock plasma on adrenocortical cell function

G Kéri, V. Parameswaran, Donald D. Trunkey et al. · Life Sciences · 1981 · 33 citations

Inflammation, Cardiogenic Shock, Septic Shock Plasma +4

Novel, Selective CDK9 Inhibitors for the Treatment of HIV Infection

Gábor Németh, Zoltán Varga, Zoltán Greff et al. · Current Medicinal Chemistry · 2011 · 32 citations

The somatostatin analogue peptide TT-232 induces apoptosis and chromosome breakage in cultured human lymphocytes

Anna Tompa, M Jakab, J. Major et al. · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · 2000 · 13 citations

Somatic Variant, Autoimmune Disease, Tt-232 Induces Apoptosis +10